A business not making money doesn't guarantee stock decline, as seen with Amazon. Regulus Therapeutics' cash burn rate and runway are crucial factors for shareholders to consider despite its lack of revenue. Analyzing its cash burn trajectory and potential for growth is essential for long-term investment decisions.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay